Register for email alerts and news feeds:
This journal | BMJ Group
rss
Annals of the Rheumatic Diseases 1999;58:303-308; doi:10.1136/ard.58.5.303
Copyright © 1999 BMJ Publishing Group Ltd & European League Against Rheumatism.
Ann Rheum Dis 1999;58:303-308 ( May )

Extended reports

HLA-DRB1 alleles associated with polymyalgia rheumatica in northern Italy: correlation with disease severity Carlo Salvarani,a Luigi Boiardi,a Vilma Mantovani,b Andrea Ranzi,c Fabrizio Cantini,d Ignazio Olivieri,e Michela Bragliani,b Elisa Collina,b PierLuigi Macchionia

a Servizio di Reumatologia, Arcispedale S Maria Nuova, Reggio Emilia, Italy, b Laboratorio Centralizzato, Settore Tipizzazione Tissutale, Ospedale S Orsola-Malpighi, Bologna, Italy, c Cattedra di Biometria e Statistica Medica, Istituto di Igiene, Università di Modena, Italy, d Unità Reumatologica, Ospedale di Prato, Prato, Italy, e Unità di Reumatologia, Ospedale S Carlo, Potenza, Italy

Correspondence to: Dr C Salvarani, Servizio di Reumatologia, Azienda Ospedaliera Arcispedale S Maria Nuova, V le Umberto 1 N50, 42100 Reggio Emilia, Italy.

Accepted for publication 15 February 1999

OBJECTIVE---To examine the association of HLA-DRB1 alleles with polymyalgia rheumatica (PMR) in a Mediterranean country and to explore the role of HLA-DRB1 genes in determining disease severity.
METHODS---A five year prospective follow up study of 92 consecutive PMR patients diagnosed by the secondary referral centre of rheumatology of Reggio Emilia, Italy was conducted. HLA-DRB1 alleles were determined in the 92 patients, in 29 DR4 positive rheumatoid arthritis (RA) patients, and in 148 controls from the same geographical area by polymerase chain reaction amplification and oligonucleotide hybridisation.
RESULTS---No significant differences were observed in the frequencies of HLA-DRB1 types and in the expression of HLA-DRB 70-74 shared motif between PMR and controls. The frequency of the patients with double dose of epitope was low and not significantly different in PMR and in controls. No significant differences in the distribution of HLA-DR4 subtypes were observed between DR4+ PMR, DR+ RA, and DR4+ controls. Results of the univariate analysis indicated that an erythrocyte sedimentation rate (ESR) at diagnosis > 72 mm 1st h, the presence of HLA-DR1, DR10, rheumatoid epitope, and the type of rheumatoid epitope were significant risk factors associated with relapse/recurrence. Cox proportional hazards modelling identified two variables that independently increased the risk of relapse/recurrence: ESR at diagnosis > 72 mm 1st h (RR=1.5) and type 2 (encoded by a non-DR4 allele) rheumatoid epitope (RR=2.7).
CONCLUSION---These data from a Mediterranean country showed no association of rheumatoid epitope with PMR in northern Italian patients. A high ESR at diagnosis and the presence of rheumatoid epitope encoded by a non-DR4 allele are independent valuable markers of disease severity.


© 1999 by Annals of the Rheumatic Diseases

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Pease, C. T., Haugeberg, G., Montague, B., Hensor, E. M. A., Bhakta, B. B., Thomson, W., Ollier, W. E. R., Morgan, A. W. (2009). Polymyalgia rheumatica can be distinguished from late onset rheumatoid arthritis at baseline: results of a 5-yr prospective study. Rheumatology (Oxford) 48: 123-127 [Abstract] [Full Text]  
  • Salvarani, C., Macchioni, P., Manzini, C., Paolazzi, G., Trotta, A., Manganelli, P., Cimmino, M., Gerli, R., Catanoso, M. G., Boiardi, L., Cantini, F., Klersy, C., Hunder, G. G. (2007). Infliximab plus Prednisone or Placebo plus Prednisone for the Initial Treatment of Polymyalgia Rheumatica: A Randomized Trial. ANN INTERN MED 146: 631-639 [Abstract] [Full Text]  
  • Caporali, R., Cimmino, M. A., Ferraccioli, G., Gerli, R., Klersy, C., Salvarani, C., Montecucco, C., for the Systemic Vasculitis Study Group of the Ita, (2004). Prednisone plus Methotrexate for Polymyalgia Rheumatica: A Randomized, Double-Blind, Placebo-Controlled Trial. ANN INTERN MED 141: 493-500 [Abstract] [Full Text]  
  • Salvarani, C., Cantini, F., Boiardi, L., Hunder, G. G. (2002). Polymyalgia Rheumatica and Giant-Cell Arteritis. NEJM 347: 261-271 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

BMJ Careers - Latest Rheumatology Jobs

Rheumatology Jobs